Problems associated with unauthorised repair of rigid scopes
Published
Related content
-
TGA review of the benefits and risks of TAVNEOS (avacopan)
We are reviewing new information that has raised concerns regarding the integrity and reliability of the clinical trial data that supported the approval of TAVNEOS (avacopan) in Australia. -
Medical device adverse event monitoring update
An update about expected increases in the number of medical device incident reports reported to the TGA -
Atrium Medical products - US consent decree on manufacturing facility
The TGA is aware of regulatory action undertaken by the US Food and Drug Administration (FDA) in relation to the Maquet manufacturing facility in Hudson, New Hampshire, USA